INTERACTION OF PHXA41, A NEW PROSTAGLANDIN ANALOG, WITH PILOCARPINE - A STUDY ON PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE

被引:77
|
作者
FRISTROM, B
NILSSON, SEG
机构
[1] Department of Ophthalmology, University of Linköping
关键词
D O I
10.1001/archopht.1993.01090050096037
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective.-To evaluate the effects of PhXA41, a new prostaglandin analogue, on the intraocular pressure (IOP) in patients receiving pilocarpine treatment and the effects of pilocarpine in patients receiving PhXA41 treatment. Design.-Twenty patients with ocular hypertension were randomized into two parallel groups. The treatment period was 2 weeks. Ten patients in group 1 were given PhXA41 twice daily during week 1 and, in addition, pilocarpine three times daily during week 2. Ten patients in group 2 received pilocarpine three times daily during week 1 and PhXA41 twice daily in addition during week 2. PhXA41 was used in a concentration of 0.006%, and pilocarpine was given in a concentration of 2%. Main Outcome Measures.- In group 1, the mean IOP on day 0 was 25.1 mm Hg; on day 7,19.1 mm Hg; and on day 14,17.6 mm Hg. In group 2, the mean IOP on day 0 was 23.8 mm Hg; on day 7,20.4 mm Hg; and on day 14,17.7 mm Hg. Results.-PhXA41 had a clinically significant IOP-lowering effect (23.4% reduction on day 7 as compared with baseline day (P<.001). The corresponding value with pilocarpine was 14.3% (P<.001). When pilocarpine was added to PhXA41, the additional IOP reduction was 7.4% (P<.01) compared with 14.2% (P<.01) when PhXA41 was added to pilocarpine. The two groups were found to have an almost equal reduction in IOP on day 14 (group 1, 29.4%; group 2, 26.6%). No serious adverse reactions were seen. Some conjunctival hyperemia in the PhXA41-treated eyes was noted on day 7, as compared with the pilocarpine-treated eyes, but there were few complaints of discomfort. Conclusions.-This study indicated that PhXA41 could be useful in the treatment of glaucoma, as monotherapy, or in certain cases in combination with pilocarpine.
引用
收藏
页码:662 / 665
页数:4
相关论文
共 50 条
  • [21] EFFECT OF PHXA34, A NEW PROSTAGLANDIN (PG) DERIVATIVE, ON INTRAOCULAR-PRESSURE (IOP) AFTER TOPICAL APPLICATION TO GLAUCOMATOUS MONKEY EYES
    JUSTIN, N
    WANG, RF
    CAMRAS, CB
    STIERNSCHANTZ, J
    BITO, LZ
    PODOS, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 947 - 947
  • [22] EFFECT OF PILOCARPINE DROPS ON DIURNAL INTRAOCULAR-PRESSURE VARIATION IN PATIENTS WITH GLAUCOMA
    WORTHEN, DM
    INVESTIGATIVE OPHTHALMOLOGY, 1976, 15 (09): : 784 - 787
  • [23] PATTERN-ERG IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
    PAPST, N
    BOPP, M
    SCHNAUDIGEL, OE
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1984, 185 (05) : 390 - 392
  • [24] TIMOLOL IN THE TREATMENT OF ELEVATED INTRAOCULAR-PRESSURE - A MULTICENTER STUDY
    NIELSEN, NV
    ACTA OPHTHALMOLOGICA, 1981, 59 (03): : 442 - 442
  • [25] THE OCULAR EFFECTS OF PROSTAGLANDINS AND THE THERAPEUTIC POTENTIAL OF A NEW PGF(2-ALPHA) ANALOG, PHXA41 (LATANOPROST), FOR GLAUCOMA MANAGEMENT
    BITO, LZ
    STJERNSCHANTZ, J
    RESUL, B
    MIRANDA, OC
    BASU, S
    JOURNAL OF LIPID MEDIATORS, 1993, 6 (1-3): : 535 - 543
  • [26] COMFORT OF LEVOBUNOLOL AND METIPRANOLOL IN A DOUBLE-BLIND-STUDY IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
    OBER, M
    SCHARRER, A
    NOVACK, GD
    LUE, JC
    OPHTHALMOLOGICA, 1986, 192 (03) : 159 - 164
  • [27] The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure
    Strahlman, ER
    Vogel, R
    Tipping, R
    Clineschmidt, CM
    Lewis, R
    Keates, E
    Quigley, H
    Zimmerman, T
    Abelson, MB
    Allen, RC
    Brown, RH
    Cacioppo, LR
    Cyrlin, MN
    Gieser, DK
    Greenidge, KC
    Gross, RL
    Karp, DW
    Koby, MM
    Kass, M
    Laibovitz, R
    McMahon, CD
    Ostrov, CS
    Walters, T
    Ritch, R
    Samples, JR
    Schuman, SJ
    Serle, J
    VelaThomas, MA
    Boyle, J
    Lippa, E
    Reines, S
    Strahlman, E
    Strohmaier, K
    OPHTHALMOLOGY, 1996, 103 (08) : 1283 - 1293
  • [28] ARTERIAL-HYPOTENSION IN LOW OR MODERATELY ELEVATED INTRAOCULAR-PRESSURE GLAUCOMA PATIENTS
    BRESSONDUMONT, H
    BECHETOILLE, A
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1995, 18 (02): : 128 - 134
  • [29] EFFECT OF TOPICAL ENALAPRILAT (MK-422) IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
    SHEDDEN, AH
    KRUPIN, T
    FEITL, M
    PANEBIANCO, D
    VOGEL, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S823 - S823
  • [30] ARTERIAL-HYPOTENSION IN LOW OR MODERATELY ELEVATED INTRAOCULAR-PRESSURE GLAUCOMA PATIENTS
    BRESSONDUMONT, H
    BECHETOILLE, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1840 - 1840